Tower Research Capital LLC (Trc) Black Diamond Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Black Diamond Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 12,343 shares of BDTX stock, worth $26,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,343

Previous 1,040 1086.83%

Holding current value

$26,907

Previous $4,000 1225.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.2 - $6.58 $47,472 - $74,373	11,303 Added 1086.83%	12,343 $53,000
Q2 2024 Aug 13, 2024	SELL	$4.65 - $7.39 $19,162 - $30,454	-4,121 Reduced 79.85%	1,040 $4,000
Q1 2024 May 15, 2024	BUY	$2.67 - $5.74 $1,519 - $3,266	569 Added 12.39%	5,161 $26,000
Q4 2023 Feb 13, 2024	SELL	$1.77 - $3.03 $5,766 - $9,871	-3,258 Reduced 41.5%	4,592 $12,000
Q3 2023 Nov 14, 2023	BUY	$2.87 - $4.99 $16,456 - $28,612	5,734 Added 270.98%	7,850 $22,000
Q2 2023 Aug 14, 2023	SELL	$1.43 - $6.18 $7,880 - $34,057	-5,511 Reduced 72.26%	2,116 $10,000
Q1 2023 May 09, 2023	BUY	$1.35 - $3.14 $5,618 - $13,068	4,162 Added 120.12%	7,627 $15,000
Q4 2022 Feb 10, 2023	SELL	$1.27 - $2.51 $1,028 - $2,033	-810 Reduced 18.95%	3,465 $6,000
Q3 2022 Nov 10, 2022	SELL	$1.68 - $4.01 $302 - $721	-180 Reduced 4.04%	4,275 $7,000
Q2 2022 Aug 15, 2022	BUY	$1.5 - $3.63 $1,345 - $3,256	897 Added 25.21%	4,455 $11,000
Q1 2022 May 12, 2022	SELL	$2.66 - $5.61 $20,458 - $43,146	-7,691 Reduced 68.37%	3,558 $10,000
Q4 2021 Feb 14, 2022	BUY	$5.18 - $8.48 $45,817 - $75,005	8,845 Added 367.93%	11,249 $60,000
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $3,866 - $5,675	457 Added 23.47%	2,404 $20,000
Q2 2021 Aug 16, 2021	BUY	$12.19 - $28.17 $5,643 - $13,042	463 Added 31.2%	1,947 $24,000
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $21,229 - $33,186	-955 Reduced 39.16%	1,484 $36,000
Q4 2020 Feb 16, 2021	SELL	$29.47 - $35.0 $344,828 - $409,535	-11,701 Reduced 82.75%	2,439 $78,000
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $304,723 - $501,507	11,644 Added 466.51%	14,140 $427,000
Q2 2020 Aug 13, 2020	BUY	$22.3 - $44.8 $55,660 - $111,820	2,496 New	2,496 $105,000

Others Institutions Holding BDTX

# of Institutions

117

Shares Held

48.8M

Call Options Held

1.84M

Put Options Held

1.93M

View Full List

About Black Diamond Therapeutics, Inc.

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $79.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

More about BDTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Black Diamond Therapeutics, Inc. Transaction History